Unveiling the Miracle Tree: Therapeutic Potential of Moringa oleifera in Chronic Disease Management and Beyond
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(3), P. 634 - 634
Published: March 5, 2025
Moringa
oleifera
(MO)
has
gained
recognition
as
a
potent
natural
intervention
for
preventing
and
managing
chronic
diseases
(CDs)
due
to
its
diverse
phytochemical
composition
pharmacological
properties.
Rich
in
antioxidants,
polyphenols,
flavonoids,
glucosinolates,
MO
exerts
anti-inflammatory,
anti-hyperglycemic,
cardioprotective,
anti-obesity
effects.
These
properties
make
it
valuable
therapeutic
agent
CDs,
including
diabetes,
cardiovascular
diseases,
obesity,
neurodegenerative
disorders,
cancer.
MO’s
ability
modulate
oxidative
stress
inflammation—key
drivers
of
CDs—highlights
significant
role
disease
prevention
treatment.
enhances
insulin
sensitivity,
regulates
lipid
profiles
blood
pressure,
reduces
inflammation,
protects
against
damage.
also
modulates
key
signaling
pathways
involved
cancer
liver
prevention.
Studies
suggest
that
extracts
possess
anticancer
activity
by
modulating
apoptosis,
inhibiting
tumor
cell
proliferation,
interacting
with
pathways,
YAP/TAZ,
Nrf2-Keap1,
TLR4/NF-κB,
Wnt/β-catenin.
However,
challenges
such
variability
bioactive
compounds,
taste
acceptability,
inconsistent
clinical
outcomes
limit
their
widespread
application.
While
preclinical
studies
support
efficacy,
large-scale
trials,
standardized
formulations,
advanced
delivery
methods
are
needed
optimize
potential.
multifunctional
applications
promising
sustainable
solution
combating
especially
resource-limited
settings.
Language: Английский
Comparative therapeutic and prophylactic efficacy of ethanol and water extracts of ginger in alleviating acetaminophen-induced hepatotoxicity and dyslipidemia
Mohammed A Abdel-Rasol,
No information about this author
Nadia M. El‐Beih,
No information about this author
Wael M. El‐Sayed
No information about this author
et al.
Mediterranean Journal of Nutrition and Metabolism,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 27, 2025
Background:
Acetaminophen
(APAP)
overdose,
common
during
pandemics
like
COVID-19,
causes
liver
injury
through
oxidative
stress.
Ginger,
known
for
its
antioxidant
properties,
is
suggested
as
a
potential
natural
remedy.
Objective:
This
study
aimed
to
evaluate
the
therapeutic
and
prophylactic
efficacy
of
ethanol
ginger
extract
(GE)
suspension
(GS)
on
APAP-induced
hepatotoxicity
dyslipidemia
in
rats.
Methods:
Rats
were
assigned
ten
groups:
control
group,
dimethyl
sulfoxide
groups
receiving
either
GE
or
GS
(150
mg/kg)
two
weeks.
A
group
given
single
high
dose
APAP
(2500
mg/kg),
pre-treated
with
before
APAP,
three
repeated
doses
(500
co-administrated
along
over
Results:
administration
at
regimens
significantly
impaired
function,
defenses,
lipid
metabolism.
These
disruptions
included
reduced
levels
markers
such
glutathione
(GSH),
catalase
(CAT),
superoxide
dismutase
(SOD),
S-transferase
(GST),
reductase
(GR),
peroxidase
(GPx),
glucose-6-phosphate
dehydrogenase
(G6PDH).
Lipid
metabolism
alterations
evident
from
increased
triacylglycerols
(TAGs),
total
cholesterol
(T-chol),
low-density
lipoprotein
(LDL-chol),
alongside
decreased
high-density
(HDL-chol).
The
resulted
severe
damage,
indicated
by
elevated
malondialdehyde
(MDA),
alanine
aminotransferase
(ALT),
alkaline
phosphatase
(ALP),
altered
protein
fractions.
Both
treatments
alleviated
these
changes,
particularly
MDA,
ALT,
GPx,
LDL-chol
levels.
demonstrated
superior
protective
effects
compared
GS,
restoring
GSH,
ALP,
CAT,
SOD,
GST,
GR,
G6PDH,
HDL-chol,
albumin
alpha-1
globulins.
In
contrast,
showed
slightly
greater
reducing
TAGs
T-chol
Conclusions:
Ginger
extracts
offer
significant
protection
against
damage
dyslipidemia,
providing
more
pronounced
effects.
Language: Английский